Highlights
The world's first oncolytic bacterial carrier
YB1, the world's only oncolytic bacterial carrier with independent technology patents, can carry different drug warheads to accurately target solid tumors and cause tumor ablation
It is safe and effective, and can self replicate in a large number of tumors
The target of tumor can be regulated by oxygen, which can reduce the damage to normal organs greatly, and the safety is the highest. Moreover, it can be reproduced in large quantities in the tumor, which can significantly improve the drug concentration in the tumor
Strong drug delivery capability
In addition, YB1 has the strongest drug carrying capacity among oncolytic vectors. It can carry protein drugs, antibodies, mRNA, and even oncolytic viruses, which greatly enhances the therapeutic effect
High quality compatibility
It can realize the compatibility of YB1 with chemotherapy drugs, immune checkpoint antibody and car-t cell technology, and increase the curative effect and diversification
Combined with liquid biopsy of urine tumor, it can be commercialized quickly
The world's first urine free DNA biopsy technology can realize the perfect combination with YB1 treatment
